Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tipifarnib in Metastatic Malignant Melanoma
NCT00060125Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 2003
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tipifarnib in melanoma, sponsored by National Cancer Institute. Started May 2003; status: completed.
02
Drugs
tipifarnib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00060125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00060125.